Luca Richeldi

25PUBLICATIONS
94CO-AUTHORS
Immunogenetics (incl. genetic immunology)AllergyPredictive and prognostic markersBiomedical imagingCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Sep 07, 2026
Contemporary Concise Review 2025: Interstitial Lung Disease.

|Jul 14, 2026
Acute exacerbation in fibrotic interstitial lung disease: an international working group report.

|Jul 30, 2024
Concordance and Prognostic Relevance of Different Definitions of Systemic Sclerosis Interstitial Lung Disease Progression.

Enrico De Lorenzis, Francesco Del Galdo, Gerlando Natalello

|Feb 14, 2024
Zinpentraxin Alfa for Idiopathic Pulmonary Fibrosis: The Randomized Phase III STARSCAPE Trial.

Luca Richeldi, Courtney Schiffman, Jürgen Behr

|Jan 04, 2024
Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on 'Feels, Functions, Survives'. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory Agency.

Ganesh Raghu, Marya Ghazipura, Thomas R Fleming

|Sep 14, 2023
Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with progressive pulmonary fibrosis (FIBRONEER-ILD).

Toby M Maher, Shervin Assassi, Arata Azuma

Pageof 5

Frequent Collaborators

5 joint publications

Toby M Maher

5 joint publications

Fernando J Martinez

4 joint publications

Ganesh Raghu

4 joint publications

Vincent Cottin